Study about the efficacy of metformin to immune function in cancer patients

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2014
INTERVENTION: Administering metformin. CONDITION: cancer and sarcoma PRIMARY OUTCOME: Ability to produce cytokines (IL‐2, TNF alpha, IFN gamma) and differentiation (memory, regulatory etc.) in peripheral blood T cells. INCLUSION CRITERIA: 1. Subjects who received a full explanation of the study and gave a written informed consent. 2. Subjects who can complain abnormal and subjective symptoms if they suffer from them during the study.
Epistemonikos ID: 16be3d26fb70c6ec6184acf63374c9d0b381f25a
First added on: Aug 22, 2024